MCR synthesis of praziquantel derivatives

Chem Biol Drug Des. 2012 Apr;79(4):470-7. doi: 10.1111/j.1747-0285.2011.01288.x. Epub 2012 Jan 30.

Abstract

Schistosomiasis, a high volume neglected tropical disease affecting more than 200 million people worldwide, can only be effectively treated by the tetrahydroisoquinoline drug praziquantel (PZQ). Herein, we describe an efficient approach to access PZQ derivatives by the Ugi 4-component reaction followed by the Pictet-Spengler reaction in a two-step, one-pot procedure. 30 novel PZQ derivatives are described based on the Ugi 4-component reaction and an X-ray structure of a novel derivative revealing different conformation compared with PZQ is discussed. Several analogues comparable in activity to the drug PZQ have been identified based on an in vitro Schistosoma mansoni worm viability assay.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anthelmintics / chemical synthesis
  • Anthelmintics / chemistry*
  • Anthelmintics / pharmacology*
  • Chemistry Techniques, Synthetic / methods
  • Cricetinae / parasitology
  • Crystallography, X-Ray
  • Humans
  • Models, Molecular
  • Praziquantel / chemical synthesis
  • Praziquantel / chemistry*
  • Praziquantel / pharmacology*
  • Schistosoma mansoni / drug effects*
  • Schistosomiasis / drug therapy
  • Schistosomiasis mansoni / drug therapy

Substances

  • Anthelmintics
  • Praziquantel